Zenith Drugs Ltd

NSE: ZENITHDRUG · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹42.15
Market cap: ₹72.28 Cr
Revenue (annual): ₹171.2 Cr
Net profit (annual): ₹3.94 Cr
P/E (TTM): 18.3×Sector 47.3×
Promoter holding: 69.98%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All New Order Win 5 Annual General Meeting 4 Capital Structure Change 3 Other Announcement 2 Financial Results 2 Capacity Expansion 2 Results Correction 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 May 2026 18:39 IST NSE

Financial Results

Zenith Drugs H2 FY26 Results: Net Profit ₹1.6 Cr, Up 14.3% YoY

Zenith Drugs Ltd reported revenue from operations of ₹93 Cr (+41.8% YoY) and net profit of ₹1.6 Cr (+14.3% YoY) for H2 FY26.

Key figure: Net profit ₹1.6 Cr · +14.3% YoY

Open full results → Read the filing ↗

29 May 2026 18:39 IST NSE

Financial Results

Zenith Drugs Financial Results

Zenith Drugs Limited reported audited financial results for the year ended March 31, 2026. The board also appointed internal auditors for the upcoming fiscal year.

Read the filing ↗